{"name":"Cellular Sciences, inc.","slug":"cellular-sciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQ2hDWnkybkVwbVFDbUhQMzU3YW9WSmpCdkMwN3VPeDNVOHQwTVZDVm1OcTBBN3JYdXBLeE93RFgyenJPa1JFM1pONlgzV2RpeTNnOFYwS25wbGRyWVp5VEh5Uk04RUphUWtYVmJ1OVBZUEh5Wm9HaFZoakstUlZHNlphSzh2SW9URjdMSEMzWUpyLURvZFlfWFltTzczcVRRODJ6TlctakFkeE0?oc=5","date":"2026-03-24","type":"deal","source":"Fierce Biotech","summary":"Gilead's $2.2B Ouro buyout delivers autoimmune T-cell engager, new purpose for Galapagos - Fierce Biotech","headline":"Gilead's $2.2B Ouro buyout delivers autoimmune T-cell engager, new purpose for Galapagos","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPbnZxcmhlTVcxTUQ1UU5jNEpnX3hGX0RIcjk1S3Q2WDRUU1UxbTMyODJCZ0NWWlI2WDVSSGVtelJFNHJ5cnF1Y3o1ZVByOUpxYjVWQTZoWE5ZT19GalpIT0RwTzVpYWNYN29Bcy12eVlmZTJQN1VYSXZIREl2NldRdGN6YUtYb0NCZktwbmhlZHZOTGJJem1Sc2VoX21hS0hqWkJHV1RKSlQ?oc=5","date":"2026-02-23","type":"deal","source":"BioPharma Dive","summary":"Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy - BioPharma Dive","headline":"Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFA4MW1uWXFaMEZKWnVLS2Uxb3pDNDNWaGdKcEdOZk5DVGNkNC1MMW5YWnQ4aGtOUnN3NEVCUEdST01POVBVbWFTSHI3SW5sbzA5NnduUk1DX056eXJyMU5HTU12d9IBaEFVX3lxTE1RSTBaZ0FBWTZoWUVHZ05NUktLTmxwVFFxRFQwRDRCWWRRTUlxa2R1c3VlS2hwZU9KVmFIU2t6ZExqMmFHOHZEc3NCbjFrbnQzQjNYMWdHRXoxNlhUN201N0RIenh3b0Jz?oc=5","date":"2026-02-09","type":"pipeline","source":"BioInformant","summary":"Big Pharma Makes M&A Moves to Secure Positions in In Vivo Cell Engineering - BioInformant","headline":"Big Pharma Makes M&A Moves to Secure Positions in In Vivo Cell Engineering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOS3VnQlVReFJoMzhxNkxvNURqNHl4TUpLWDlmNVJ6NVdma1V4TkNqb2lzVy0ydUluTzEtdTRNLVZpaTJSeG16dGhUdXpTWC1mWVc5YlJWOHlzVm9wYVhNNE5KSUJYTmpvTUE3bjl4dUlobHZRd3BNbzlSbWlLWDB1WTZXUVR2VmZkX1ZnODVpYw?oc=5","date":"2026-01-05","type":"pipeline","source":"PharmTech.com","summary":"FUJIFILM Irvine Scientific Becomes FUJIFILM Biosciences - PharmTech.com","headline":"FUJIFILM Irvine Scientific Becomes FUJIFILM Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPcUdNWDA2bVhCdzY3THRzV2Q3NjNNMkNWbXpsbk42RThsLU9RWTFqb3dnbzA2SFBpTGJEN2plLXN0MDBpQWFSQTNLUzRyWUhSOGlDTWhqOF9DV2ZzN1FVSmUxRmExSVBkd3RsLUxzczFIeUkwcFJoeDhGa19hcmxKb2R5TWR5ZTE3bWt5WV9RSDhUalRaQ0s4N3V0SDJlaFdJanc?oc=5","date":"2025-10-17","type":"pipeline","source":"BioSpace","summary":"Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back - BioSpace","headline":"Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNY0xZWUItZzcwb3J5OEFyd3l1WWhKSE84dFZJN0drYTN4QXN3Zno5d1B1TDlUMmdmOWQzTDIyclM0Y1F5MnJYbG1ZdTRZZlFhb3Jmem14RzcwZlkwOXVnQWZsaURwTXliQWNDbVp3aFdtY3FwT01xQlhaSUZwXzByQkNXUDd5alg1c09zU2prbzREQWJ1cFpqS1JLdzNYX0RvZkd3SE42T0hIZ2lXektpSk5vaTk0NXZmWHdtWEhzSTk0OFZUeFE?oc=5","date":"2025-10-09","type":"pipeline","source":"Citeline News & Insights","summary":"Big Pharma Still Sees Value In Cell And Gene Therapy’s Next Wave - Citeline News & Insights","headline":"Big Pharma Still Sees Value In Cell And Gene Therapy’s Next Wave - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxOYUZ2YTFuMEluVzFfaERBTjNrRTQ5TThUM243RkFFblBzdFZ4NVJNUU8ybDJrZlpjbWo2WmJCa3BWTXBscWVSUmt2eTZmZTU1S0N4WTFHTnFENzU2NDNfVUk5em9KNWRXY3dKM0tlWExVUDVkNzZOQTFfZjR4U18xWkYxZTEtOUMzV1kwNFN0V3M0X1RyMWZlek01VkwwZVAzSXp1OGZVYlJOMHE5cGx1c3pWclN5YVQ2dXJodUJYTTBpTzRBcFkyelVKVTBSSHpNWW52d24yRV9mdk5vN25rQjdJWkc5ZkFqV0d0ZnlyUDFGZW5vVVFUelpYMHhuSFBudEloY0tHdTFXbzVkWnRSTW1MUzl1NHhWcE9ldTFmODhEWGw3T0FXeDVDTk9fTXZWX0htMzNVSzRrVDNDVWtSYnRoM3JrMVVrR05hYU1mN1ppMG0xeDhOOGdWYw?oc=5","date":"2025-09-08","type":"deal","source":"PR Newswire","summary":"Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia - PR Newswire","headline":"Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0NkF6b19LV0tyUGtYbmYteHhWX1V0Vzc5WHVGaUZpNEgxT1hQLUVvZzJzN3FmcS1rOTlmampHcm9iMEtfdk0tYjlERmo5bEwyWFVTQUktSTh5NXllRjBN?oc=5","date":"2025-08-27","type":"pipeline","source":"nature.com","summary":"Single-cell transcriptomic analysis of blood and bronchoalveolar lavage fluid in progressive fibrosing interstitial lung diseases - nature.com","headline":"Single-cell transcriptomic analysis of blood and bronchoalveolar lavage fluid in progressive fibrosing interstitial lung","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQYkVXVThacWRYTjhGRlpiY280QVR0bzUtNEhhSl9ZNzgzOFpzYklkRWk3eWNERF93LXVtQ2FxNEFZN1lzdWtpNlhFRU1nYjVham9waFVmaEFSSjF2Y0JtVEpQNXdzM0xfX1dCcEFqOU9DVEdqNUlScl9TdWlON0RIb0dRWkY0M2kxUzdCbzRUSkU?oc=5","date":"2025-06-27","type":"patent","source":"Yahoo Finance","summary":"Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science - Yahoo Finance","headline":"Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Sc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPenFBQm83UHZLbV9RZTVtSDIzZHRIVHg3OUpObndHQzNuVXhEeXIwcjFFc1VwRUpBYVBoZjVmNDE1WElodkdzY1Y1WUdoVFFTb3ZHNDRxdGFmazJ2TWdkR05uTzMyYkJQcGZmTW9jdFpxUDFxWmZlRXpWZ1lHb2VuSllhbXdmTVpleFRGYkl3VXV1bFd1WmxYaW1mYWgwanNRQXlyWk16clBrNmlyYWc1Z1NKSVcwVm45YVlJZ2FBUEZyWEYzeWZhVFFRV1Y?oc=5","date":"2025-06-01","type":"pipeline","source":"Reuters","summary":"Gilead's CAR-T cell therapy shows promise in deadly brain cancer - Reuters","headline":"Gilead's CAR-T cell therapy shows promise in deadly brain cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPV1VtOWc2UzA5UmtEOERnRXhEdEtsc0pIMXdSVXlmcnV1S0lCdVB5a09UbTEyakRMUThlREJoMzBBWndUUG9XeW5Yc2ZKbkFwTlZrR3NneUh2TkhYOThYSUNhVmwzbFRyWl9TTnN6VGlkVUJBVHY2RnRkc3h0MFI1enc1SE5mb3hvSUFTcGFsWnJKb01EMjkxWnIwck5wOFliVmpHQzM4MUVGalRFQTNR?oc=5","date":"2025-05-06","type":"pipeline","source":"Fierce Pharma","summary":"AstraZeneca debuts $300M cell therapy manufacturing facility in Maryland - Fierce Pharma","headline":"AstraZeneca debuts $300M cell therapy manufacturing facility in Maryland","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}